PBM-Owned Mail Order Pharmacies Do Not Result In Higher Costs – FTC
This article was originally published in The Pink Sheet Daily
Executive Summary
PDP sponsors generally paid less for drugs purchased through PBM-owned mail order pharmacies in 2002 and 2003 than for drugs purchased through mail-order or retail pharmacies not owned by PBMs, according to an FTC report.
You may also be interested in...
Caremark Looks Beyond Price Pressures From Retail, Health Plan-Owned PBMs
Despite competition from “captive” pharmacy benefit managers, Caremark is expecting 8%-10% more revenue growth in 2006 than the current year.
Caremark Looks Beyond Price Pressures From Retail, Health Plan-Owned PBMs
Despite competition from “captive” pharmacy benefit managers, Caremark is expecting 8%-10% more revenue growth in 2006 than the current year.
PBM Conflict Of Interest Study Begins: FTC Contacting 20 PBMs, Pharmacies
The Federal Trade Commission will study whether using a PBM-owned mail order pharmacy costs more than using a non-PBM mail order or retail pharmacy. The study was mandated by the Medicare Rx law.